Literature DB >> 15287726

Zinc ions trigger conformational change and oligomerization of hepatitis B virus capsid protein.

Stephen J Stray1, Pablo Ceres, Adam Zlotnick.   

Abstract

Assembly of virus particles in infected cells is likely to be a tightly regulated process. Previously, we found that in vitro assembly of hepatitis B virus (HBV) capsid protein is highly dependent on protein and NaCl concentration. Here we show that micromolar concentrations of Zn2+ are sufficient to initiate assembly of capsid protein, whereas other mono- and divalent cations elicited assembly only at millimolar concentrations, similar to those required for NaCl-induced assembly. Altered intrinsic protein fluorescence and highly cooperative binding of at least four Zn2+ ions (KD approximately 7 microM) indicated that binding induced a conformational change in capsid protein. At 37 degrees C, Zn2+ enhanced the initial rate of assembly and produced normal capsids, but it did not alter the extent of assembly at equilibrium. Assembly mediated by high zinc concentrations (> or =300 microM) yielded few capsids but produced a population of oligomers recognized by capsid-specific antibodies, suggesting a kinetically trapped assembly reaction. Comparison of kinetic simulations to in vitro assembly reactions leads us to suggest that kinetic trapping was due to the enhancement of the nucleation rate relative to the elongation rate. Zinc-induced HBV assembly has hallmarks of an allosterically regulated process: ligand binding at one site influences binding at other sites (cooperativity) indicating that binding is associated with conformational change, and binding of ligand alters the biological activity of assembly. We conclude that zinc binding enhances the kinetics of assembly by promoting formation of an intermediate that is readily consumed in the reaction. Free zinc ions may not be the true in vivo activator of assembly, but they provide a model for regulation of assembly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15287726     DOI: 10.1021/bi049571k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

1.  Exploring the paths of (virus) assembly.

Authors:  Paul Moisant; Henry Neeman; Adam Zlotnick
Journal:  Biophys J       Date:  2010-09-08       Impact factor: 4.033

2.  Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1.

Authors:  Christina R Bourne; M G Finn; Adam Zlotnick
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

3.  Simulation study of the contribution of oligomer/oligomer binding to capsid assembly kinetics.

Authors:  Tiequan Zhang; Russell Schwartz
Journal:  Biophys J       Date:  2005-10-07       Impact factor: 4.033

4.  A reaction landscape identifies the intermediates critical for self-assembly of virus capsids and other polyhedral structures.

Authors:  Dan Endres; Masaki Miyahara; Paul Moisant; Adam Zlotnick
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

5.  Viruses and the physics of soft condensed matter.

Authors:  Adam Zlotnick
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

6.  Classical nucleation theory of virus capsids.

Authors:  Roya Zandi; Paul van der Schoot; David Reguera; Willem Kegel; Howard Reiss
Journal:  Biophys J       Date:  2005-12-30       Impact factor: 4.033

7.  In vitro screening for molecules that affect virus capsid assembly (and other protein association reactions).

Authors:  Adam Zlotnick; Angela Lee; Christina R Bourne; Jennifer M Johnson; Paul L Domanico; Stephen J Stray
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

8.  Exploring the parameter space of complex self-assembly through virus capsid models.

Authors:  Blake Sweeney; Tiequan Zhang; Russell Schwartz
Journal:  Biophys J       Date:  2007-10-05       Impact factor: 4.033

9.  Zinc-dependent interaction between JAB1 and pre-S2 mutant large surface antigen of hepatitis B virus and its implications for viral hepatocarcinogenesis.

Authors:  Jye-Lin Hsu; Woei-Jer Chuang; Ih-Jen Su; Wen-Jun Gui; Yu-Ying Chang; Yun-Ping Lee; Yu-Lin Ai; David T Chuang; Wenya Huang
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

10.  Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA.

Authors:  Robyn Puro; Robert J Schneider
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.